Risk factors and therapeutic response in Chinese patients with peptic ulcer disease

Table 3 The impact of therapeutic efficacy according to co-medications and ulcer location of patients n (%)

Co-medications	Therapeutic efficacy		Total	P-value
	Ulcer healed	Ulcer unhealed
None
Positive H. pylori infection	159 (75.7)	51 (24.3)	210	0.370a
Negative H. pylori infection	140 (71.8)	55 (28.2)	195
ASP
Positive H. pylori infection	8 (80)	2 (20)	10	0.195b
Negative H. pylori infection	12 (100)	0	12
NSAID
Positive H. pylori infection	6 (60)	4 (40)	10	0.035b
Negative H. pylori infection	11 (100)	0	11

^aPearson’s χ² test;

^bFisher’s exact test. ASP: Aspirin.